Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, machine learning models using CT scans and clinical data can predict survival and metastasis risk before bladder cancer surgery, with some models achieving high accuracy.
No, adding mitomycin to BCG did not improve disease-free survival in high-risk NMIBC patients in a large randomized trial.
Yes, early evidence suggests dose intensification to visible tumors may improve outcomes for intermediate- or high-risk prostate cancer, but ongoing trials will clarify safety…
The pooled overall complication rate for Thulium Fiber Laser lithotripsy is about 10.4%, with major complications (Clavien-Dindo III-V) occurring in about 1.2% of cases.
Yes, darolutamide combination therapy improves survival in metastatic hormone-sensitive prostate cancer, with a 32% reduction in risk of death when added to ADT plus docetaxel.
Yes, darolutamide plus ADT significantly delays pain progression in metastatic hormone-sensitive prostate cancer, based on the ARANOTE phase 3 trial.
Creating a calming environment with soft lighting, music, and lavender scent can significantly lower anxiety levels in women with overactive bladder before medical procedures.
Research suggests that exposure to plastic chemicals like BPA can alter gut health and gene activity, potentially leading to male infertility that may affect future generations.
Anti-inflammatory interventions show promise for treating male infertility, particularly in cases involving varicocele or immune-mediated testicular disorders, though more…
Disitamab vedotin plus a PD-1 inhibitor shows high response rates in urothelial carcinoma, with objective response rates of 71% in first-line metastatic disease and 51% in…
No, OPDIVO QVANTIG is not FDA-approved for urothelial carcinoma; it is approved for renal cell carcinoma and melanoma only.
Adding mitomycin to BCG does not improve disease-free survival for high-risk non-muscle invasive bladder cancer compared to BCG alone.
Yes, ThuLEP generally results in a shorter hospital stay than RASP for large BPH, though some studies show no difference.
After prostate resection for BPH, the risk of developing bladder stones is low but increases with certain factors like larger prostate volume, higher symptom scores, and elevated…
Yes, a randomized controlled trial found that watching an animated video before a transperineal prostate biopsy significantly reduced pain during the procedure and improved…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.